Data Demonstrate Dose-Dependent Pharmacologic Activity of Emixustat in Patients with Geographic Atrophy Associated with Dry Age-Related Macular Degeneration SEATTLE--(BUSINESS WIRE)-- Acucela Inc. (TOKYO: 4589), a clinical-stage ... CNBC, 1 month ago
Phase 2a clinical trial results for emixustat hydrochloride published - CPhI.cn, 1 month ago
Acucela : Announces Publication of Phase 2a Clinical Trial Results for Emixustat Hydrochloride - 4 Traders, 1 month ago
2 images for "Emixustat Hydrochloride"
Emixustat (Macular Edema and Macular Degeneration) Market 2023 New Research Report Published By Radiant Insights
Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch ...Digital Journal, 2 weeks ago
Research and Markets (http://www.researchandmarkets.com/research/2jj835/retinopathy_of) has announced the addition of the "Retinopathy Of Prematurity - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive ...Individual.com, 3 weeks ago Research and Markets: Retinopathy Of Prematurity Therapeutics Pipeline Review, H1 2015 - 6 Companies & 8 Drug Profiles BioMedReports, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!